Phospholipid methylation and the synaptosomal uptake of mediator amino acids

The decrease in neurotransmitter amino acid uptake was observed in rat brain synaptosomes incubated with S-adenosyl-L-methyl-methionine. The inhibitory effect of neurotransmitter as a consequence of methylation of synaptic membrane is more pronounced in stimulatory transmitter amino acids. The effect of phospholipids on amino acid uptake in rat brain synaptosomes decreases with age.     

Regulation of synaptosomal tyrosine hydroxylation in different brain regions with noradrenergic innervation

Tyrosine hydroxylation rate was measured by a modified tritium release assay at the physiological pH of 7.4 in synaptosomes prepared from cerebellum, hippocampus and hypothalamus. Incubation in the presence of 2 mM 8 bromo cAMP increased tyrosine hydroxylation in all three regions. An almost identical activation was seen after membrane depolarization by 50 mM K⁺. Removal of Ca²⁺ from the incubation medium had no significant effect on the activation produced by either agent, however it did significantly increase the control tyrosine hydroxylation rate in the hypothalamus. The combined effect of 8 Br cAMP and high K⁺ was found to be additive in the cerebellum and hippocampus but not in the hypothalamus. A reduction in tyrosine hydroxylation was observed if incubation was carried out in the presence of 1 μM noradrenaline; the degree of inhibition was similar in the three regions. 2 mM 8 Br. cAMP added to the noradrenaline restored tyrosine hydroxylation to control levels in synaptosomes from the hypothalamus, but not the hippocampus and cerebellum. Tyrosine hydroxylase in the hypothalamus is associated with dopaminergic nerve terminals as well as noradrenergic nerve terminals derived from more than one cell group, the hippocampus and cerebellum however both receive their noradrenergic input entirely from the locus coeruleus. Differences between synaptosomes from the three brain regions may therefore reflect differences in the nature of the enzyme as well as local regulatory mechanisms.     

Neurotransmitter uptake in various brain regions of chronically morphinized rats

Rats were long-term morphine-intoxicated by a fluid-diet model ensuring an equal nutrient intake in morphinized and control rats. Uptake of neurotransmitters and D-ala²-met⁵-enkephalinamide (Enk) was studied in the particulate fractions (obtained at 10,000g) from well defined brain regions of long-term intoxicated and morphine withdrawn rats. In control animals the accumulation of [³H]glutamate and [³H]-aminobutyric acid (GABA) reached the highest tissue/medium (T/M) ratio values, 30–120, in the regions studied while monoamine T/M values were 2–10. No active uptake of [³H]Enk could be demonstrated. Striatum showed the most evident modifications in neurotransmitter uptake. In this region the equilibrium T/M ratio for [³H]glutamate and [³H]GABA was significantly lower in intoxicated rats versus controls. Moreover, the T/M ratio for [³H]5-hydroxytryptamine (5-HT) was lower, while that for [³H]dopamine (DA) was higher in abstinent rats in comparison with the controls. [³H]glutamate and [³H]GABA uptakes were also significantly lower, respectively, in frontal cortex, hippocampus and brain stem in intoxicated rats, while [³H]5-HT uptake was significantly lower in hypothalamus after morphine withdrawal. The possible involvement of the endogenous opioid system in the etiology of the alterations is discussed.     

N- and C-terminal amino acids of proteolipids from the rat brain and various other organs

N- and C-terminal amino acids of proteolipid proteins from the whole brain and some other organs were investigated. N-terminal amino acids were identified by the dansylation procedure. C-terminal amino acids were determined after the enzymatic hydrolysis with carboxy peptidases A and B with the following dansylation. Phenyl alanine and lysine were identified as C-terminal amino acids of the proteolipids from the whole brain and only lysine--as the C-terminal amino acid of proteolipids from the heart, liver, kidney (cortical and medullary parts) and skeletal muscle. The corresponding N-terminal amino acids of the proteolipids from the whole brain were aspartic acid and glycine and of proteolipids from the heart, liver, kidney (cortical and medullary parts) and skeletal muscle--only aspartic acid. A comparison of the data obtained with the previous ones has shown that in the brain there exist only two types of proteolipids--one characteristic of myelin, another-- of mitochondria, and in other organs--only one characteristic of mitochondria.     

Stimulation of synaptosomal uptake of neurotransmitter amino acids by insulin: possible role of insulin as a neuromodulator

Insulin stimulates in a dose-dependent manner (concentration range of 0.1 - 10 microM) the synaptosomal uptake of amino acids characterized by high-affinity, Na+-dependent, veratridine-sensitive transport systems. This stimulation is observed in synaptosomes prepared from each of several regions of the adult rat brain. Both the initial rate of amino acid uptake and the overall capacity for amino acid accumulation are increased. Since these transport systems have been associated with the neurotransmitter role of the amino acids, we postulate that insulin can modulate neurotransmission in the rat central nervous system by increasing the efficiency of neuroactive amino acid reuptake.     

Beta-adrenergic control of brain uptake of large neutral amino acids

The amino acids tyrosine and tryptophan are precursors of physiologically active amines in the central nervous system. To reach the brain they have to compete with other large neutral aminio acids (LNAA) for the normally saturated carrier by which these amino acids are transported into the brain. The beta-adrenergic agonist isoprenaline is demonstrated to cause an increase in the brain concentration of most LNAA without a concomitant decrease in any of them. This finding indicates that the transport of LNAA into the brain is regulated by a beta-adrenergic mechanism.     

Characteristics of a lysosomal membrane transport system for tyrosine and other neutral amino acids in rat thyroid cells

Tyrosine countertransport was used to demonstrate the existence of a carrier system for neutral amino acids in the lysosomal membrane of FRTL-5 thyroid cells. In addition to tyrosine, the carrier system recognized the neutral amino acids leucine, histidine, phenylalanine, and tryptophan. Cystine and lysine, amino acids for which a lysosomal carrier system has been demonstrated, showed no competition with tyrosine for countertransport. The tyrosine system showed stereospecificity and cation independence. It did not require an acidic lysosome or the availability of free thiols. The apparent Km for tyrosine was approximately 100 microM; the energy of activation of the system was approximately 9.7 kcal/mol. This new lysosomal membrane carrier system for neutral amino acids resembles the plasma membrane L system in 3T3 Chinese hamster ovary cells and melanoma B-16 cells.     

Levels and uptake of taurine in various brain regions after druginduced generalized convulsions

In a study of the role of taurine in the genesis of epilepsy the effects of metrazol-induced convulsions on the uptake and distribution of taurine in the brain were measured.In vivo we found no significant uptake of taurine in the mouse brain; in rabbit brain in most areas significant taurine uptake was found. The physiological levels of taurine were much higher in mouse brain than in rabbit brain.In vivo the regional levels and the uptake of taurine were not significantly changed after generalized convulsions. Uptakein vivo was lowered in slices obtained from mice treated with metrazol. The lack of effect of metrazol convulsions on cerebral taurinein vivo indicates that further studies are needed to clarify the relationship between taurine, a putative inhibitory transmitter, and epilepsy.Supported in part by a grant from the C.N.R., Rome, Italy     

Reactions of partially purified tyrosine phenol lyase with threonine and other amino acids

Both enantiomers of threonine are transformed to α-ketobutyrate with a partially purified preparation of tyrosine phenol lyase from the cells of Escherichia intermedia A-21. Allothreonine does not undergo the same reaction but is, instead, converted to glycine. The action of tyrosine phenol lyase on a number of other α-amino acids was also studied. The inversion of configuration at C-2 due to the exchange of the α-proton is not a general phenomenon. The mechanism of action of tyrosine phenol lyase on d-amino acids is discussed.     

Diaminopimelic acid uptake by Bacillus megaterium: influence of growth conditions and other amino acids

Diaminopimelic acid (DAP) uptake was studied in Bacillus megaterium. The K _m and V _max were determined for bacteria grown with or without DAP. The uptake of DAP was shown to be constitutive and unaffected by the presence of other amino acids (including cystine). The concentration of DAP and lysine in the amino acid pool was examined and a procedure for pulse-labelling cell walls developed.     

Transformation of some hydroxy amino acids to other amino acids

It has been observed that -hydroxy--amino acids are transformed into other amino acids, when heated in dilute solutions with phosphorous acid, phosphoric acid or their ammonium salts. It has been shown that as in the case of previously reported glycine-aldehyde reactions, glycine also reacts with acetone to give -hydroxyvaline under prebiologically feasible conditions. It is suggested, therefore, that the formation of -hydroxy--amino acids and their transformation to other amino acids may have been a pathway for the synthesis of amino acids under primitive earth conditions.     

Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions

To date, UCM707, (5Z,8Z,11Z,14Z)-N-(3-furylmethyl)eicosa-5,8,11,14-tetraenamide, has the highest potency and selectivity in vitro and in vivo as inhibitor of the endocannabinoid uptake. Its biochemical, pharmacological and therapeutic properties have been intensely studied recently, but the information on its capability to modify neurotransmitter activity, which obviously underlies the above properties, is still limited. In the present study, we conducted a time-course experiment in rats aimed at examining the neurochemical effects of UCM707 in several brain regions following a subchronic administration (5 injections during 2.5 days) of this inhibitor in a dose of 5 mg/kg weight. In the hypothalamus, the administration of UCM707 did not modify GABA contents but reduced norepinephrine levels at 5 h after administration, followed by an increase at 12 h. Similar trends were observed for dopamine, whereas serotonin content remained elevated at 1 and, in particular, 5 and 12 h after administration. In the case of the basal ganglia, UCM707 reduced GABA content in the substantia nigra but only at longer (5 or 12 h) times after administration. There were no changes in serotonin content, but a marked reduction in its metabolite 5HIAA was recorded in the substantia nigra. The same pattern was found for dopamine, contents of which were not altered by UCM707 in the caudate-putamen, but its major metabolite DOPAC exhibited a marked decrease at 5 h. In the cerebellum, UCM707 reduced GABA, serotonin and norepinephrine content, but only the reduction found for norepinephrine at 5 h reached statistical significance. The administration of UCM707 did not modify the contents of these neurotransmitters in the hippocampus and the frontal cortex. Lastly, in the case of limbic structures, the administration of UCM707 markedly reduced dopamine content in the nucleus accumbens at 5 h, whereas GABA content remained unchanged in this structure and also in the ventral-tegmental area and the amygdala. By contrast, norepinephrine and serotonin content increased at 5 h in the nucleus accumbens, but not in the other two limbic structures. In summary, UCM707 administered subchronically modified the contents of serotonin, GABA, dopamine and/or norepinephrine with a pattern strongly different in each brain region. So, changes in GABA transmission (decrease) were restricted to the substantia nigra, but did not appear in other regions, whereas dopamine transmission was also altered in the caudate-putamen and the nucleus accumbens. By contrast, norepinephrine and serotonin were altered by UCM707 in the hypothalamus, cerebellum (only norepinephrine), and nucleus accumbens, exhibiting biphasic effects in some cases.     

Higher environmental temperature-induced change in synaptosomal acetylcholinesterase activity of brain regions

Expcsure of adult male albino rats to higher environmental temperature (HET) at 35° for 2–12 hr or at 45° for 1–2 hr increases hypothalamic synaptosomal acetylcholinesterase (AChE) activity. Synaptosomal AChE activity in cerebral cortex of rats exposed to 35° for 12 hr and in cerebral cortex and pons-medulla of rats exposed to 45° for 1–2 hr are also activated. AChE activity of synaptosomes prepared from normal rat brain regions incubated in-vitro at 39° or 41° for 0.5 hr increases significantly in cerebral cortex and hypothalamus. The activation of AChE in ponsmedulla is also observed when this brain region is incubated at 41° for 0.5 hr. Increase of (a) the duration of incubation at 41° and (b) the incubation temperature to 43° under in-vitro condition decreases the synaptosomal AChE activity. Lioneweaver-Burk plots indicate that (a) in-vivo and invitro HET-induced increases of brain regional synaptosomal AChE activity are coupled with an increase ofV _max without any change inK _m (b) very high temperature (43° under in-vitro condition) causes a decrease inV _max with an increase inK _m of AChE activity irrespective of brain regions. Arrhenius plots show that there is a decrease in transition temperature in hypothalamus of rats exposed to either 35° or 45°; whereas such a decrease in transition temperature of the pons-medulla and cerebral cortex regions are observed only after exposure to 45°. These results suggests that heat exposure increases the lipid fluidity of synaptosomal membrane depending on the brain region which may expose the catalytic site of the enzyme (AChE) and hence activate the synaptosomal membrane bound AChE activity in brain regions. Further the in-vitro higher temperature (43°C)-induced inhibition of synaptosomal AChE activity irrespective of brain regions may be the cause iof partial proteolysis/disaggregation of AChE oligomers and/or solubilization of this membrane-bound enzyme.To whom to address reprint requests: